Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Percutaneous Portal Vein Recanalization (PVR) by Interventional Radiology for the Management of Refractory Portal Hypertension in Children With Non-cirrhotic Extrahepatic Portal Vein Obstruction.

NCT07873021 is registered in ClinicalTrials.gov with Papa Giovanni XXIII Hospital as lead sponsor.

NCT NCT07873021
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07873021 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Percutaneous Portal Vein Recanalization (PVR) by Interventional Radiology for the Management of Refractory Portal Hypertension in Children With Non-cirrhotic Extrahepatic Portal Vein Obstruction.
Lead sponsor
Papa Giovanni XXIII Hospital
Phase
Observational
Overall status
Active, not recruiting
Start date
January 1, 2022
Completion date
May 31, 2028
Enrollment
33 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cavernous transformation of portal vein, extrahepatic portal vein obstruction (ehpvo), hypertension, portal, interventional radiology, percutaneous portal vein recanalization (pvr), portal vein thrombosis